Study Identifies Biomarkers To Help Detect Alzheimer’s

by Paromita Datta published on -

Scientists may just have found a way of predicting whether a person can develop Alzheimer’s. A study by a Spanish research team, published in the journal Brain, found a set of biomarkers that can help us predict if a person with mild cognitive impairment (MCI) has a high risk of developing dementia. The discovery was made as the researchers were studying the changes in the brain with the progression of the disease. [1]

MCI is the phase that falls between normal aging and Alzheimer’s. The early diagnosis of possible Alzheimer’s can help us develop better treatment strategies. The team monitored the brain activity of 54 patients with MCI for every six months for three years. They studied hypersynchronization, the connectivity between the different regions of the brain at each stage.



A confused old man suffering from dementia looking at the calendar on the wall

Hypersynchronization was taken as a point of measurement. People with MCI who go on to develop Alzheimer’s show increased levels of synchronization. However, this decreases as Alzheimer’s progresses, showing a dysfunctioning cortical network. Changes were observed in the fronto-temporal and fronto-occipital regions as the disease worsened. Protection Status
Last updated -
About the Author

Paromita Datta covers the latest health and wellness trends for Organic Facts. An ex-journalist who specialized in health and entertainment news, Paromita was responsible for managing a health supplement for The New Indian Express, a leading national daily in India. She has completed her post-graduation in Business Administration from the University of Rajasthan and her diploma in journalism from YMCA, Delhi. She has completed an e-course, Introduction to Food and Health, from Stanford University, US.

Rate this article
Average rating 0.0 out of 5.0 based on 0 user(s).